Skip to Content

Skip over Generic Navigation

Skip over Subnavigations

Skip over Sitemap

Investor Update

Basel, 25 May 2012

New Drug Application Filed for Anti-Cancer Agent “Pertuzumab” for the Treatment of HER2-Positive Metastatic or Recurrent Breast Cancer

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.

Services

© 2013 F. Hoffmann-La Roche Ltd

Legal Statement

14.11.2012

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.